Researchers Identify Mechanism Behind CBD’s Anti-inflammatory Effects

in Recent researchResearchers have gained important insight into the mechanisms behind cannabinoids, specifically focusing on the non-psychoactive cannabinoid CBD and how it reduces inflammation. New Atlas Report. Inflammation contributes to everything from skin breakouts (hence the inclusion of CBD in beauty products) to medical conditions such as asthma, autoimmune diseases and even cardiovascular disease.

As a refresher, cannabinoids are a class of compounds found in the cannabis plant (phytocannabinoids) and naturally produced in the human body (endocannabinoids). These compounds interact with the endocannabinoid system, a complex network of receptors and neurotransmitters that play key roles in regulating a variety of physiological processes, which the human body benefits from ingesting the cannabis plant. It’s a big argument that it’s naturally set up like this.

Cannabinoids interact with CB1 and CB2 receptors. CB1 receptors are mainly present in the brain and central nervous system, whereas CB2 receptors are abundant in immune cells and peripheral tissues. The interactions between cannabinoids and these receptors affect a wide range of bodily functions, many of which we are still learning and understanding, including mood, pain response, and fighting inflammation. where I am.

Inflammation is important for the body’s defense mechanisms, but excessive inflammation can have adverse effects, such as chronic pain. CBD has become an important alternative to opioids in pain management, especially in terms of harm reduction. Inflammation is the root cause of many medical conditions, and the ability of cannabinoids, especially CBD, to balance inflammation is perhaps one of the most important medical understandings of our time.

Thanks in part to such research, cannabis continues to grow from drug war purgatory to acceptance in the medical community.

In a leaked letter to the Drug Enforcement Administration (DEA), the Department of Health and Human Services recently classified cannabis as a Schedule I (classification of substances considered to have high potential for abuse and not currently approved for medical use). ) to be reclassified. For treatment in the United States, it complies with Schedule III, demonstrating recognized medical benefit under the Controlled Substances Act.

This latest study is a move toward federal legalization, if not a schedule change, as most activists would very much like the United States to at least downgrade cannabis from a Schedule I drug. As we move forward, we continue to add more scientific merit to cannabis. As research into botanical medicine grows, this current classification becomes increasingly irrational.

The cannabis plant contains over 100 different cannabinoids, including cannabidiol (CBD), the all-star delta-9-tetrahydrocannabinol (THC), and the lesser-known cannabigerol (CBG). CBD has been legal since the passage of the 2018 Farm Bill, which legalizes the cultivation of hemp plants with less than 0.3 percent CBD content.

Researchers already knew that cannabinoids, especially CBD, had anti-inflammatory properties, but the exact conspiracy behind their action was not fully understood. Researchers at the Friedrich Schiller University in Jena, Germany, have set out to change this by embarking on a mission to investigate eight bioactive cannabinoids, including CBD, THC and CBG. Their mission is to uncover how these compounds interact with essential pro-inflammatory enzymes, which can wreak havoc on the body when the presence of lipid mediators (LMs) becomes chronic, any inflammation. To investigate the relationship with lipid mediators (LM), which are the conductors of the phase. And despite their frequent detractors, they managed to make us all understand why CBD plays such an important role in reducing inflammation.

“We found that all eight cannabinoids we studied had anti-inflammatory properties,” said lead author Lucas Peltner of the study. “We found that all the compounds we studied inhibited the formation of pro-inflammatory messenger substances in cells, while promoting the formation of substances that resolved inflammation.”

And of all the cannabinoids they studied, CBD emerged as the winner when it came to regulating the immune response. Unraveling the science: Researchers have pinpointed CBD’s activation of the 15-lipoxygenase (15-LOX) enzyme, which produces pro-degradation mediators (SPMs). These SPMs play a role in halting inflammatory processes, assisting tissue regeneration, and restoring body homeostasis. Their research also shows that CBD can suppress the production of inflammatory molecules known as leukotrienes.

The results were first demonstrated in cultured cells and then confirmed in mice. However, many people who use CBD can say that CBD can actually reduce inflammation, explaining the cannabinoid’s ability to everything from glowing skin to relieving pain. .

“CBD kind of induces a switch in the affected cells, directing the inflammatory process from stimulatory to inhibitory,” said Paul Jordan, one of the study’s corresponding authors.

While this understanding is welcome to the cannabis community, many medical cannabis patients, especially those who use cannabis for pain rather than night creams, also enjoy and benefit from the psychoactive effects of THC. It’s worth noting what you’re receiving. Remember, while CBD has value, it does not provide the guilt-free well-being that many patients enjoy. That’s why, more than ever. Federal legalization is needed so that people can enjoy CBD from full-spectrum cannabis flowers. By doing so, you get a better entourage effect, where the cannabinoids work more effectively together.